VELTA WILLIS: Open Payments
NPI 1831207935 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,800 in 171 payments from 34 companies in 2025. Trend: 2023 $3,606 · 2024 $3,520 · 2025 $3,800
Food & beverage: $3,530Education: $270
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $351 |
| Eisai Inc. | 18 | $308 |
| Astellas Pharma US Inc | 11 | $281 |
| PFIZER INC. | 11 | $220 |
| Novartis Pharmaceuticals Corporation | 14 | $206 |
| Daiichi Sankyo Inc. | 11 | $201 |
| SEAGEN INC. | 2 | $200 |
| Janssen Biotech, Inc. | 7 | $156 |
| TAIHO ONCOLOGY, INC. | 10 | $147 |
| Genmab U.S., Inc. | 10 | $147 |
Products named: Lenvima, KEYTRUDA, ENHERTU, Vyloy, LONSURF, CABOMETYX, Camcevi, ELREXFIO.
Industry payments across NY — which companies pay providers there.
